欢迎来到天天文库
浏览记录
ID:32228942
大小:1.48 MB
页数:39页
时间:2019-02-01
《恩替卡韦对慢性乙肝患者血清中hbv+dna载量与tgfβ1的影响》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、遵义医学院硕十学位论文中文摘要恩替卡韦对慢性乙肝患者血清中HBVDNA载量与TGF.p1的影响摘要目的:观察慢性乙肝患者经恩替卡韦治疗前后乙肝病毒载量(HBVDNA)与血清中TGF.B1变化,分析其疗效,为临床合理应用恩替卡韦治疗慢性乙肝提供参考。方法:按随机原则选取63例恩替卡韦试验组及对照组的慢性乙肝患者。试验组33例,其中轻度患者9例、中度患者17例、重度患者7例,分别口服恩替卡韦0.5mg每日一次,同时加用一般护肝药;对照组30例,其中轻度患者13例、中度患者12例、重度患者5例,单用一般护肝药。分别在治疗前、治疗3
2、个月、治疗6个月收集血清,检测血清中HBVDNA、TGF.131的含量,观察其变化。以HBVDNA载量与TGF.131为主要指标,采用SPSS13.0系统软件进行统计分析,比较治疗前后两者的变化。结果:恩替卡韦试验组轻度、中度和重度患者血清中HBVDNA载量治疗后呈下降趋势,治疗3月、6月与治疗前比较(P3、0.05)有统计学差异。试验组与对照组(重度患者)血清TGF.B1水平治疗6月相比(尸<0.05)有统计学差异。结论:恩替卡韦对慢性乙肝血清中的TGF.p1与乙肝病毒载量(HBVDNA)有影响,慢性乙肝轻度、中度及重度患者经恩替卡韦治疗后血清中的HBVDNA载量明显下降,同时慢性乙肝重度患者血清中的TGF.Bl水平明显下降。慢性乙肝重度患者经恩替卡韦治疗后效果较好。关键词:恩替卡韦;乙肝病毒载量;TGF.D1遵义医学院硕十学位论文英文摘要EffectsofEntecavironHBVDNAandTGF.B1inserumso4、fpatientschronichepatititBAbstractObjective:ToinvestigatehepatitisBviralload(HBVDNA)andserumTGF.B1changesinchronichepatitisBpatientsbeforeandafterentecavirtreatment,tounderstandtheeffectofentecavir,inordertoprovideareferencetheclinicalapplicationofentecavirtreatchr5、onichepatitisB.Methods:Thereareenticavirtestgroupandcontrolgroupwho63caseswithchronichepatitisBpatientsareselectedrandomly.Testgroup33cases,including9casesofmild,17casesofmoderate,7casesofseverepatients.Entecavir0.5mgonceaday,whilethegeneralhepatoprotectivedrugareg6、iven;Controlgroup30cases,including13casesofmild,12casesofmoderate,5casesofseverepatients.Thegeneralhepatoprotectivedrugaregiven.ToobservethechangesinSerumHBVDNAandTGF..131whenbepreparedtreatment,treatmentin3months,in6monthsrespectively.WithhepatitisBviralloadandTGF7、一131asthemainindicatorsusedSPSSl3.0systemsoftwareforstatisticalanalysis,comparingbetweenthechangesbeforeandaftertreatment.Results:EntecavirtestgroupincludchronichepatitisBmild,moderateandseverepatientswhoesSerumHBVDNAaredecreased.Therearestatisticallysignificantdif8、ferenceinSerumHBVDNAthatcomparetreatmentin3monthsandin6monthswithbepreparedtreatmentp
3、0.05)有统计学差异。试验组与对照组(重度患者)血清TGF.B1水平治疗6月相比(尸<0.05)有统计学差异。结论:恩替卡韦对慢性乙肝血清中的TGF.p1与乙肝病毒载量(HBVDNA)有影响,慢性乙肝轻度、中度及重度患者经恩替卡韦治疗后血清中的HBVDNA载量明显下降,同时慢性乙肝重度患者血清中的TGF.Bl水平明显下降。慢性乙肝重度患者经恩替卡韦治疗后效果较好。关键词:恩替卡韦;乙肝病毒载量;TGF.D1遵义医学院硕十学位论文英文摘要EffectsofEntecavironHBVDNAandTGF.B1inserumso
4、fpatientschronichepatititBAbstractObjective:ToinvestigatehepatitisBviralload(HBVDNA)andserumTGF.B1changesinchronichepatitisBpatientsbeforeandafterentecavirtreatment,tounderstandtheeffectofentecavir,inordertoprovideareferencetheclinicalapplicationofentecavirtreatchr
5、onichepatitisB.Methods:Thereareenticavirtestgroupandcontrolgroupwho63caseswithchronichepatitisBpatientsareselectedrandomly.Testgroup33cases,including9casesofmild,17casesofmoderate,7casesofseverepatients.Entecavir0.5mgonceaday,whilethegeneralhepatoprotectivedrugareg
6、iven;Controlgroup30cases,including13casesofmild,12casesofmoderate,5casesofseverepatients.Thegeneralhepatoprotectivedrugaregiven.ToobservethechangesinSerumHBVDNAandTGF..131whenbepreparedtreatment,treatmentin3months,in6monthsrespectively.WithhepatitisBviralloadandTGF
7、一131asthemainindicatorsusedSPSSl3.0systemsoftwareforstatisticalanalysis,comparingbetweenthechangesbeforeandaftertreatment.Results:EntecavirtestgroupincludchronichepatitisBmild,moderateandseverepatientswhoesSerumHBVDNAaredecreased.Therearestatisticallysignificantdif
8、ferenceinSerumHBVDNAthatcomparetreatmentin3monthsandin6monthswithbepreparedtreatmentp
此文档下载收益归作者所有